CeloNova Biosciences, Inc. – Trademark Portfolio
Entity Type: 03
CeloNova Biosciences, Inc. holds 43 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 37 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 6 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include EMBOZENE, ONCOZENE, and POLYZENE. The owner is based in Peachtree City, GA.
Suite 100
401 Westpark Court
Peachtree City, GA 30269
Showing of trademarks Trademarks
Trademark Classifications
CeloNova Biosciences, Inc.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Frequently Asked Questions
How many trademarks does CeloNova Biosciences, Inc. have?
CeloNova Biosciences, Inc. has 43 U.S. trademarks filed with the USPTO. Of these, 3 registered, 28 abandoned, 12 cancelled.
What trademark classes does CeloNova Biosciences, Inc. file in?
CeloNova Biosciences, Inc. files trademarks across 6 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 1 (Chemicals), Class 40 (Treatment & Processing). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are CeloNova Biosciences, Inc.'s most well-known trademarks?
CeloNova Biosciences, Inc.'s registered trademark portfolio includes well-known marks such as EMBOZENE, ONCOZENE, and POLYZENE. These are among 3 currently registered trademarks in the portfolio.
What is CeloNova Biosciences, Inc.'s trademark registration success rate?
CeloNova Biosciences, Inc. has a 7% trademark registration rate, with 3 out of 43 resolved applications resulting in successful registration. Currently, 0 applications are pending review.